5-羟基-6-甲基烟酸 | 7428-22-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 5-羟基-6-甲基烟酸
• 英文名称: 2-Methyl-3-hydroxy-pyridin-5-carbonsaeure
• 英文别名: 5-Hydroxy-6-methylnicotinic acid；5-hydroxy-6-methylpyridine-3-carboxylic acid
• CAS: 7428-22-0
• 化学式: C₇H₇NO₃
• 分子量: 153.137
• InChiKey: NYEFWJFPBFRRKU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  70.4
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  4-Methyl-5-propoxy-oxazol 、 顺丁烯二酸 以74%的产率得到
  参考文献：
  名称：

  EFREMENKO A. A.; SKLYAROV L. YU.; GUNAR V. I., XIM.-FARMATSEVT. ZH., 1977, 11, HO 2, 89-91

  摘要：

  DOI：

文献信息

• BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS
  申请人：Baynes Brian M.

  公开号：US20120301950A1

  公开（公告）日：2012-11-29

  Provided herein are methods for the production of difunctional alkanes in microorganisms. Also provided are enzymes and nucleic acids encoding such enzymes, associated with the difunctional alkane production from carbohydrates feedstocks in microorganisms. The invention also provides recombinant microorganisms and metabolic pathways for the production of difunctional alkanes.

  本文提供了在微生物中生产双官能基烷烃的方法。同时还提供了编码这种酶的核酸和酶，与从碳水化合物饲料中生产双官能基烷烃相关。本发明还提供了重组微生物和代谢途径，用于生产双官能基烷烃。
• Biological Synthesis of Difunctional Hexanes and Pentanes from Carbohydrate Feedstocks
  申请人：Baynes Brain M.

  公开号：US20130017593A1

  公开（公告）日：2013-01-17

  Provided herein are methods for the production of difunctional alkanes in microorganisms. Also provided are enzymes and nucleic acids encoding such enzymes, associated with the difunctional alkane production from carbohydrates feedstocks in microorganisms. The invention also provides recombinant microorganisms and metabolic pathways for the production of difunctional alkanes.

  本文提供了在微生物中生产二官能烷的方法。同时还提供了编码这些酶的酶和核酸，这些酶与从碳水化合物饲料中生产二官能烷有关。本发明还提供了重组微生物和代谢途径，用于生产二官能烷。
• N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS
  申请人：Active Biotech AB

  公开号：US20160115158A1

  公开（公告）日：2016-04-28

  A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.

  化合物(I)的配方，或其药学上可接受的盐和包含该化合物的药物组合物。该化合物是S100A9与相互作用伙伴如RAGE、TLR4和EMMPRIN之间相互作用的抑制剂，因此在治疗癌症、自身免疫性疾病、炎症性疾病和神经退行性疾病等疾病中有用。
• METHODS FOR DETECTING ALZHEIMER'S DISEASE
  申请人：BG Medicine, Inc.

  公开号：EP1869474A1

  公开（公告）日：2007-12-26
• Methods for Detecting Alzheimer's Disease
  申请人：Damian Doris

  公开号：US20090211346A1

  公开（公告）日：2009-08-27

  Markers are provided that are predictive of Alzheimer's disease. Levels of these markers, when different from a standard, are indicative of a patient being at risk of having or developing Alzheimer's disease.